An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Ipamorelin: Benefits, Dosage & Risks (2025) Huddle Men's Health In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few The science behind the peptide craze Scientific American FDA Lifts Ban on Key Peptides Slim 'n Sleek FDA Peptide Reclassification 2026: What It Means for Providers